Prostate cancer treatment for economically disadvantaged men All analyses, interpretations, and conclusions herein are those of the authors and not the State of California.
dc.contributor.author | Parsons, J. Kellogg | en_US |
dc.contributor.author | Kwan, Lorna | en_US |
dc.contributor.author | Connor, Sarah E. | en_US |
dc.contributor.author | Miller, David C. | en_US |
dc.contributor.author | Litwin, Mark S. | en_US |
dc.date.accessioned | 2010-03-01T20:22:40Z | |
dc.date.available | 2011-02-01T20:36:36Z | en_US |
dc.date.issued | 2010-03-01 | en_US |
dc.identifier.citation | Parsons, J. Kellogg; Kwan, Lorna; Connor, Sarah E.; Miller, David C.; Litwin, Mark S. (2010). "Prostate cancer treatment for economically disadvantaged men All analyses, interpretations, and conclusions herein are those of the authors and not the State of California. ." Cancer 116(5): 1378-1384. <http://hdl.handle.net/2027.42/65051> | en_US |
dc.identifier.issn | 0008-543X | en_US |
dc.identifier.issn | 1097-0142 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/65051 | |
dc.description.abstract | BACKGROUND. The authors compared the types of treatments prostate cancer patients received from county hospitals and private providers as part of a statewide public assistance program. METHODS. This was a cohort study of 559 men enrolled in a state-funded program for low-income patients known as Improving Access, Counseling, and Treatment for Californians With Prostate Cancer (IMPACT). Multinomial regression was used to compare types of treatments patients received from different providers. RESULTS. Between 2001 and 2006, 315 (56%) participants received treatment from county hospitals and 244 (44%) from private providers. There were no significant between-group differences with respect to age ( P = .22), enrollment year ( P = .49), Charlson comorbidity index ( P = .47), Gleason sum ( P = .33), clinical T stage ( P = .36), prostate-specific antigen ( P = .39), or D'Amico risk criteria ( P = .45). Participants treated by private providers were more likely than those treated in county hospitals to be white (35% vs 10%, P < .01) and less likely to undergo surgery (29% vs 54%, P < .01). Multinomial regression analyses showed that participants treated by private providers were nearly 2½ times more likely than those treated by public providers to receive radiotherapy (odds ratio [OR], 2.36; 95% confidence interval [CI], 1.37-4.07) and >4½ times more likely to receive primary androgen deprivation (OR, 4.71; 95% CI, 2.15-10.36) than surgery. CONCLUSIONS. In this economically disadvantaged cohort, prostate cancer treatments differed significantly between county hospitals and private providers. These data reveal substantial variations in treatment patterns between different types of healthcare institutions that—given the implications for health policy and quality of care—merit further scrutiny. Cancer 2010. © 2010 American Cancer Society. | en_US |
dc.format.extent | 132257 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Wiley Subscription Services, Inc., A Wiley Company | en_US |
dc.subject.other | Life and Medical Sciences | en_US |
dc.subject.other | Cancer Research, Oncology and Pathology | en_US |
dc.title | Prostate cancer treatment for economically disadvantaged men All analyses, interpretations, and conclusions herein are those of the authors and not the State of California. | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Oncology and Hematology | en_US |
dc.subject.hlbsecondlevel | Public Health | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Urology, University of Michigan, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationother | Division of Urologic Oncology, Moores Comprehensive Cancer Center, University of California San Diego, La Jolla, California ; Department of Surgery, Urology Section, Veterans Affairs Medical Center, San Diego, California ; Fax: (619)-543-6573 ; UCSD Division of Urology, 200 West Arbor Drive, #8897, San Diego, CA 92103-8897 | en_US |
dc.contributor.affiliationother | Johnsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California | en_US |
dc.contributor.affiliationother | Department of Urology, University of California Los Angeles, Los Angeles, California | en_US |
dc.contributor.affiliationother | Johnsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California ; Department of Urology, University of California Los Angeles, Los Angeles, California ; Department of Health Services, University of California Los Angeles, Los Angeles, California | en_US |
dc.identifier.pmid | 20101733 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/65051/1/24856_ftp.pdf | |
dc.identifier.doi | 10.1002/cncr.24856 | en_US |
dc.identifier.source | Cancer | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.